secwatch / observer
8-K filed August 2, 2023, 7:59 PM ET ticker KALA CIK 0001479419
other confidence high sentiment neutral materiality 0.10

Kala Pharmaceuticals changes name to KALA BIO, Inc.; ticker KALA unchanged

KALA BIO, Inc.

item 5.03item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

KALA BIO, Inc.: Amended certificate of incorporation to change company name from Kala Pharmaceuticals, Inc. to KALA BIO, Inc (effective 2023-08-02).

Change
charter amendment
Effective
2023-08-02
Exact text from the filing
Effective as of 4:00 p.m., Eastern Time on August 2, 2023, Kala Pharmaceuticals, Inc. (the “Company”) amended its Restated Certificate of Incorporation, as amended (the “Certificate of Incorporation”), to effect a change of the Company’s name from “Kala Pharmaceuticals, Inc.” to “KALA BIO, Inc.”
View on SEC.gov
Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

KALA BIO, Inc.: Amended and restated bylaws solely to reflect name change to KALA BIO, Inc (effective 2023-08-02).

Change
bylaw amendment
Effective
2023-08-02
Exact text from the filing
the Board also approved an amendment and restatement of the Company’s Second Amended and Restated By-Laws solely to reflect the Name Change (as amended and restated, the “Third Amended and Restated By-Laws”) effective as of August 2, 2023
View on SEC.gov

74 governance changes filed in the last 30 days. Browse all governance changes →

KALA BIO, Inc. filing history →

Source: SEC EDGAR
accession 0001558370-23-012895
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.